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The desensitization gate of inhibitory Cys-loop
receptors
Marc Gielen1,w, Philip Thomas1 & Trevor G. Smart1
Cys-loop neurotransmitter-gated ion channels are vital for communication throughout the
nervous system. Following activation, these receptors enter into a desensitized state in which
the ion channel shuts even though the neurotransmitter molecules remain bound. To date, the
molecular determinants underlying this most fundamental property of Cys-loop receptors
have remained elusive. Here we present a generic mechanism for the desensitization of
Cys-loop GABAA (GABAARs) and glycine receptors (GlyRs), which both mediate fast
inhibitory synaptic transmission. Desensitization is regulated by interactions between the
second and third transmembrane segments, which affect the ion channel lumen near its
intracellular end. The GABAAR and GlyR pore blocker picrotoxin prevented desensitization,
consistent with its deep channel-binding site overlapping a physical desensitization gate.
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T
he presynaptic release of neurotransmitters is a prelude to
their diffusion across the synaptic cleft and subsequent
activation of postsynaptic ionotropic receptors, which
are responsible for fast chemical neurotransmission. Agonist
binding initiates the rapid opening of ligand-gated ion channels
permitting a selective ﬂow of ions through the pore. The
sustained presence of the neurotransmitter will cause
ligand-gated channels to transit from the active open-channel
agonist-bound conformation to a desensitized shut-channel,
agonist-bound state, thereby limiting current ﬂow1,2. Receptor
desensitization is a fundamental property of most ligand-gated
ion channels and can have profound physiological consequences.
These include the progressive reduction of postsynaptic current
on repetitive synaptic neurotransmitter release2–5; the pre-
desensitization of receptors by low ambient concentrations of
neurotransmitter due to spillover from active neighbouring
synapses6; and the slowing of synaptic current decays leading to
their prolongation5.
In the central nervous system, neuronal activity results from a
balance between excitation and inhibition. This is largely dictated
by the activity of excitatory ionotropic glutamate receptors, and
inhibition caused by GABA and glycine7 activating GABAA
(GABAARs) and glycine receptors (GlyRs). These latter receptors
belong to the superfamily of pentameric Cys-loop receptors that
also comprises excitatory nicotinic acetylcholine (nAChRs) and
serotonin receptors (5HT3R)7. Differential desensitization
kinetics of excitatory and inhibitory receptors has the potential
to profoundly affect the spike ﬁring proﬁles of neurons5 and thus
neural network activity. At the molecular level, desensitization of
AMPA and kainate classes of ionotropic GluRs is relatively well
understood and involves structural rearrangements at the dimer
interface between adjacent extracellular agonist-binding
domains8–11. However, for the Cys-loop GABAARs and GlyRs,
although the structure–function studies have improved our
understanding of how these receptors activate7,12, the molecular
determinants underlying the process of desensitization have yet to
be deﬁned.
Here we show that for the inhibitory neurotransmitter GABAA
and glycine receptors, the mechanism of agonist-induced
desensitization is regulated by residue interactions between the
transmembrane domains of the receptor, resulting in a time-
dependent constriction of the ion channel pore that reduces the
agonist-activated membrane conductance. This constriction has
the characteristics of a desensitization ‘gate’ that is discrete from
the ion channel gate involved in ligand-gated channel opening.
Results
Desensitization proﬁles differ between GABAA receptors. To
locate the molecular components responsible for desensitization,
we selected two GABAAR isoforms that differ markedly in their
response to supersaturating GABA concentrations (10mM) by
either desensitizing signiﬁcantly (a1b2 heteromers; percentage of
peak current desensitization (% Des)¼ 86% and weighted decay
time constant (tW)¼ 17 s) or minimally (r1 homomers, 19% Des
and 23 s, Table 1, Fig. 1a). We then constructed chimeras to ﬁrst
explore the role of the extracellular domain (ECD) by replacing
the ECD of a1 with the homologous section from r1 (r1D260-a1;
Supplementary Fig. 1). The desensitization proﬁle was similar to
that observed for wild-type a1b2 receptors (Fig. 1a), consistent
with published data13. Next we built chimeras containing M1 to
M4 and the intracellular linkers (M1–M2 and M3–M4) from
r1, coupled to the entire extracellular region of a1 or b2,
corresponding to their ECDs and the external M2–M3 linkers
(chimeras a1EXT-r1TMþ INT and b2EXT-r1TMþ INT, respectively;
Supplementary Fig. 1). Co-expression of these chimeras
supported large GABA currents with limited desensitization,
comparable to the proﬁle for wild-type r1 (Fig. 1a, see Table 1 for
all time constants and extents of desensitiszation data and
Supplementary Table 1 for GABA current amplitudes), thereby
locating the main determinants of desensitization to the
transmembrane and/or intracellular regions of the receptor.
Our primary measure of desensitization involved monitoring
the decline of currents activated by maximal saturating
concentrations of GABA. To ensure that the mutations did not
adversely perturb the general structure, function or long-term
trafﬁcking of the receptor, we monitored both the dose–response
curves and the recovery phase of the currents from desensitiza-
tion for selected mutants. Overall, the concentration–response
curves and EC50 values were minimally affected by the mutations,
though certain GABA receptor constructs did generate slightly
lower EC50 values, in accord with an increase in afﬁnity that is
often associated with desensitized receptors (Supplementary
Fig. 2). Recoveries of the maximal peak GABA currents following
desensitization were also similar for wild-type and singly mutated
receptors, with complete recovery from maximal desensitization
always achieved in mins (Supplementary Fig. 3). In addition, we
have reported both the rates and extent of desensitization for all
mutants to gain an overall view of the desensitization process
(Table 1).
Internal end of M3 and M1–M2 linker control desensitization.
We reﬁned our search using homomeric r1 receptors and
sequentially replacing individual transmembrane segments, M1 to
M3, with those from a1. These constructs yielded very small
currents, precluding analysis; however, one chimera incorporat-
ing the intracellular end of M3, the M3–M4 intracellular linker
and M4 of a1 into the r1 subunit (r1D346-a1), produced robust
currents, which strongly desensitized (%Des¼ 94% and
tW¼ 200ms, Fig. 1b).
Surprisingly, incorporating just M4 from the a1 subunit did
not affect the desensitizing phenotype of r1 (r1D433-a1, Fig. 1b).
We therefore targeted M3 in r1 and replaced six contiguous
residues at the carboxyl-terminal (C-terminal; intracellular) end
of M3 with the homologous residues from a1. This produced a
receptor (r1a1(D6-postM3)) that desensitized profoundly within
one second following activation by GABA (Fig. 1b). Within this
six amino-acid cassette, substituting just one residue, r1T349K,
was sufﬁcient to confer a rapid desensitizing proﬁle on r1
receptors (Fig. 1b).
Interestingly, on the r1a1(D6 postM3) background, incorporat-
ing the M1–M2 intracellular linker from the b2 subunit
considerably reduced desensitization towards that for wild-type
r1 (chimera r1b2(M1–M2 link)þ a1(D6-postM3), Fig. 1b). Such a
reversion was not observed after incorporating the a1 M1–M2
linker (Supplementary Fig. 4). These data indicate that the
intracellular end of M3 and the M1–M2 linker of b2 modulate
desensitization, conceivably via an intersubunit (a–b) interaction,
which is consistent with the close proximity of a1 M3 C-terminal
end to the M1–M2 linker of an adjacent b2 subunit, as seen in our
structural models (see below).
We subsequently examined this potential interaction in a1b2
GABAARs by ﬁrst introducing the M1–M2 linker of r1 into b2
subunits (b2r1(M1–M2 link)). Co-expressing this chimera with
wild-type a1 produced receptors that, unexpectedly, desensitized
almost completely at a rate 50-fold faster than wild-type a1b2
receptors (Fig. 1c). Moreover, exchanging eight residues from the
intracellular end of M3 in a1 and b2 with those from r1 resulted
in a modest three-fold increase in the desensitization rate for
a1r1(D8-postM3)b2r1(D8-postM3) (Fig. 1c). However, on this
background, reintroducing the M1–M2 linker of r1 into b2
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(a1r1(D8-postM3)b2r1(M1–M2 linkþD8-postM3), produced relatively
little effect on desensitization compared with the wild-type
receptor (Fig. 1c). If the combined effect of these two modiﬁ-
cations had been additive, we would have expected the double
chimera to desensitize even faster than the a1b2r1(M1–M2 link)
receptors. Therefore, the non-additive nature of these mutations
further supports an interaction between the intracellular end of
M3 and the M1–M2 linker, which could represent a cassette of
complementary residues conferring desensitizing properties on
the GABA ion channel.
M2 and M3 interface strongly affects GABAAR desensitization.
While the identiﬁed cassette critically modulates desensitization,
it is not the sole determinant. Indeed, exchanging the entire
transmembrane portion of M3 for a1 and b2 with r1, virtually
eliminated desensitization when these two chimeric subunits were
co-expressed (a1r1M3b2r1M3, Supplementary Fig. 5). We there-
fore compared the primary sequences for M3, and noted that the
residue homologous to V338 in r1 is a conserved leucine in other
GABAAR and GlyR subunits (Supplementary Fig. 6). By sub-
stituting these leucines for valines (a1L300Vb2L296V), we created
receptors that displayed very little desensitization (Fig. 2a).
Notably, this was achieved with very little change in the GABA
concentration–response curve for a1L300Vb2L296V compared with
that for wild-type receptors (Fig. 3), indicating the gating efﬁcacy
was minimally affected.
To understand how M3 residues could affect receptor function,
we constructed a three-dimensional (3D) model of the a1b2
GABAAR (Fig. 2a) based on the structure of the C. elegans
glutamate-gated Cl channel (GluCl) in the open conforma-
tion14, which shares high sequence homology with GABAARs and
GlyRs (Supplementary Fig. 6). In this model, the side chain of
the M3 leucine (a1L300) is orientated towards M2 near the 40
position (Fig. 2b,c; Supplementary Fig. 7), and therefore any
conformational changes to M3 may be detected in M2 by a
proximal glycine residue (a1G258) that is highly conserved in all
GABAAR and GlyR subunits (Supplementary Fig. 6).
Replacing this conserved glycine with neutral alanine in a1
and the b2 subunits (a1G258Ab2G254A) produced receptors that
desensitized 2.5-fold faster than the wild type, while mutation to
bulky hydrophobic valines (a1G258Vb2G254V) increased the
desensitization rate by 14-fold (Fig. 2a) without changing the
GABA concentration–response curve (Fig. 3).
We next assessed the importance of the highly conserved M3
valine (a1V296), which is located one a-helical turn above a1L300
(Supplementary Fig. 6). Together these residues effectively
straddle the 40 glycine (G258) in M2 (Fig. 2b). Signiﬁcantly,
their mutation to leucines in a1V296Lb2V292L strongly disrupted
desensitization, further suggesting that rearrangements to the
lower part of the M2/M3 intrasubunit interface underlies the
process of receptor desensitization (Fig. 2b).
Exploring this interface further, we examined the consequences
of mutating a1V251 and a1N307. Valine 251 is located at the  30
position intracellular to M2, bordering the M1–M2 linker, and
facing M3 at the level of a1N307 (Fig. 2b,c). Mutating a1V251 and
the homologous b2S247 to isoleucines (Fig. 2b), alanines or
aspartates (Table 1), produced a 7- to 14-fold increase in the rate
of desensitization, while phenylalanine mutants (a1V251Fb2S247F)
did not yield a resolvable current; however, the co-expression
with their wild-type counterparts (a1V251Fb2 and a1b2S247F)
created receptors desensitizing more than 20-fold faster than
wild-type a1b2 counterparts (Fig. 2b, Table 1). It is possible that
the double mutant receptors are functional but may desensitize
too rapidly to be resolved. Indeed, we used excised patch
recordings (see Methods) but still failed to resolve any current,
which may reﬂect a desensitization rate that is faster than the rate
of ion channel opening.
Similar results were obtained with the adjacent residue a1N307
and the homologous b2N303. Conservatively exchanging these
asparagines for glutamines did not affect receptor function, while
a1N307Sb2N303S and a1N307Vb2N303V receptors desensitized 15-
and 100-fold faster, respectively, compared with wild-type a1b2
(Fig. 2c, Table 1). Co-expression of a1N307D and b2N303D failed
to elicit current, but co-expression with their respective wild-type
subunits revealed 4- to 40-fold increases in desensitization
Table 1 | Weighted decay time constant for desensitization (tW) and extent of desensitization (% Des) of wild-type and mutant
GABAA and glycine receptor constructs.
Construct sW (s) % Des n Construct sW (s) % Des n
a1b2 wt 17.4±3.6 86.4±2.6 17 a1V251Ib2S247I 2.5±0.8 97.5±0.8 5
r1 wt 23.3±7.9 19±13 13 a1V251Db2S247D 1.3±0.4 93.5±1.2 4
a1V251Fb2 0.78±0.20 99.0±0.4 6
r1D260-a1 8.1±0.5 90.7±0.5 3 a1b2S247F 0.75±0.06 97.4±0.5 5
r1D346-a1 0.20±0.04 93.6±2.4 6 a1N307Qb2N303Q 11.4±1.0 90.8±0.4 4
r1D433-a1 28.2±2.6 11±4 3 a1N307Sb2N303S 1.2±0.4 97±0.9 4
r1a1(D6-postM3) 1.0±0.4 72.2±4.2 9 a1N307Vb2N303V 0.19±0.03 99.6±0.1 7
r1T349K 5.0±3.7 58.6±8.0 9 a1N307Db2 4.4±0.1 97.9±0.4 4
r1b2(M1–M2 link)þa1(D6-postM3) 10.5±3.3 25.3±8.6 10 a1b2N303D 0.41±0.12 87.1±4.1 4
a1EXT-r1TMþ INT
b2EXT-r1TMþ INT
22.9±4.0 24.3±10.9 4 a1b2g2L wt 15.5±3.2 79.8±4.5 8
a1b2r1(M1–M2 link) 0.33±0.11 98.9±0.2 11 a1b2g2LV262F 1.3±0.2 98.7±0.2 7
a1(D8-postM3)b2r1(D8-postM3) 5.8±1.3 96.1±1.1 6 a1b2g2LH318V 2.2±0.3 96.3±0.5 5
a1(D8-postM3)
b2r1(M1–M2 linkþD8-postM3)
4.6±1.5 80.4±6.2 7 GlyRa1 wt 10.7±3.4 72.4±8.1 12
a1r1 M3b2r1 M3 17.4±6.1 33.7±10.8 6 GlyRa1r1(D6-postM3) 0.88±0.23 98.2±1.0 6
a1L300Vb2L296V 26.7±12.7 25.6±5.8 11 GlyRa1L298V 17.2±6.7 64.8±6.2 3
a1G258Ab2G254A 4.9±1.4 93.5±1.5 12 GlyRa1G256V 0.84±0.16 99.6±0.3 9
a1G258Vb2G254V 1.3±0.6 93.3±1.2 8 GlyRa1V294L 17.1±6.0 14.8±8.1 7
a1V296Lb2V292L 93±15 30.4±3.3 5 GlyRa1A249F 0.85±0.65 98.0±0.9 4
a1V251Ab2S247A 2.5±0.5 96.8±0.6 5 GlyRa1N305V 0.18±0.05 98.5±1.6 5
% Des, % desensitization; wt, wild type.
Values are means±s.d., n is the number of cells recorded for each construct.
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kinetics (Table 1). The lack of current, apparent with these double
mutants, could thus be due to their profoundly enhanced rate of
desensitization. Overall these results are in complete accord with
residues located at the M2/M3 interface in the lower part of the
membrane, playing a key role in receptor desensitization.
To investigate the importance of some of the key residues at the
M2–M3 interface, and to ensure that the use of Xenopus oocytes
was not altering the desensitizing proﬁles of the GABA-activated
currents, we explored the impact of several receptor mutants when
expressed in HEK cells. As observed with the oocyte-based
experiments, the expression of a1V251Fb2 generated currents that
desensitized faster, byB10-fold compared with those for the a1b2
wild type (Supplementary Fig. 8, Supplementary Table 3). Again,
similar current proﬁles were evident by co-expressing the nearby
residue, a1N307V with the homologous b2N303V, in HEK cells
giving a sevenfold increase in the desensitization rate (Supple-
mentary Fig. 8, Supplementary Table 3).
c2 subunit M2 and M3 affects a1b2c2 GABAAR desensitization.
To initially simplify our structural approach to exploring desensi-
tization, we used a1b2 GABAARs. However, native synaptic
GABAA receptors will contain a single copy of the g2 subunit15. To
probe desensitization in the abg receptor, we examined the effect
of mutations at the intracellular end of the g2 subunit. We selected
g2V262 and g2H318 for mutation since these are homologous to
a1V251 and a1N307, respectively, which have a profound effect on
desensitization of ab receptors (Supplementary Fig. 6). While co-
expressing wild-type a1, b2 and g2L subunits produced receptors
that desensitized similarly (% Des¼ 80%, tW¼ 15.5 s) to wild-type
a1b2, mutating g2LV262F and g2LH318V increased the rate of
desensitization by 12- and 7-fold respectively, and strongly
increased the extent of desensitization (% Des¼ 98.7 and 96.3,
respectively; Fig. 4a). These mutations did not generally perturb
receptor function as GABA potency was minimally affected
at a1b2g2LV262F and a1b2g2LH318V compared with wild-type
a1b2g2L GABAARs (Supplementary Fig. 9), suggesting that
receptor gating was unaffected. Moreover, we also examined
15 s
10 mM GABA
α1 WT
β2 WT
ρ1 WT
N
CExt
Int
10 mM GABA
15 s
5 s
10 mM GABA
ρ1Δ260-α1
α1β2 WT
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α1ρ1(Δ8−postM3)
β2ρ1(M1-M2 link + Δ8−postM3)
α1β2 WT
α1β2ρ1(M1-M2 link)
Figure 1 | Intracellular end of M3 and the M1–M2 linker control
desensitization of GABAARs. (a–c) Peak-scaled membrane currents
elicited by 10mM GABA (black line), showing the desensitization phase for
the indicated receptor constructs (left column). The recovery phase is
omitted for clarity. See Table 1 for values of tw and extent of desensitization
(% Des) in all ﬁgures. The subunit chimeras are depicted by a colour code:
green (a1), red (b2) and grey (r1) (right column). Numbering refers to
the position of the interface between the two subunits in the chimera.
TM/M, transmembrane domain, INT, intracellular loops.
M4 M4
α1
β2
5 s
10 mM GABA
M2
M1 
M2 
M3 
M1
M3
5 s
α1β2 WT
α1G258Vβ2G254V
α1G258Aβ2G254A
10 mM GABA
M2
M3
M1 M2
M3
G258
5 s
α1β2 WT
10 mM GABA
V296
N307 
V251
N303
S247
L300
L296
L296
G254
V292
V292
N303
G258
α1L300Vβ2L296V
α1V251Fβ2
α1V251Iβ2S247I
α1V296Lβ2V292L
α1N307Vβ2N303V
α1N307Sβ2N303S
α1N307Qβ2N303QN307 
V251
L300
V296
Figure 2 | Mutating the intracellular end of the M2/M3 interface
regulates desensitization of a1b2 GABAARs. (a) Left: 3D model of an a1b2
GABAAR based on GluCl template. Right in a–c: membrane currents
induced by 10mM GABA. (b) Left: enlarged side view of the intracellular
end of the ion channel showing transmembrane domains M1–M3 for a1
(green) and b2 (red) subunits and the positions of various labelled residues.
(c) Left: enlarged plan view of the ion channel. Note, in b,c, M4 segments
were omitted for clarity.
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another key pharmacological facet of g2-containing GABAARs
involving modulation by benzodiazepines16. Diazepam-induced
potentiation of low concentration (EC1-2, 1–3mM) GABA
currents at wild-type a1b2g2L, and mutant a1b2g2LV262F and
a1b2g2LH318V receptors, remained unaltered (2.53±0.20-fold
(a1b2g2L); 2.14±0.16-fold (a1b2g2LV262F); and 2.51±0.05-fold
(a1b2g2LH318V), n¼ 3), again suggesting that the mutations have
neither affected gating, nor assembly, nor the folding of the
receptors. It is important to note that, since there is only one copy
of the g2 subunit per a1b2g2 receptor pentamer, there is also only
one copy of the g2 subunit mutation, further emphasizing the
importance of the cytoplasmic end of the M2/M3 interface on the
desensitization of Cys-loop receptors.
A similar mechanism accounts for the desensitization of GlyRs.
If the identiﬁed residues in GABAARs form a part of the generic
mechanism for receptor desensitization at inhibitory Cys-loop
receptors, then we should be able to replicate the effects in GlyRs.
Applying saturating concentrations (10mM) of glycine to GlyR
a1 homomeric receptors (GlyRa1) evoked peak currents that
desensitized by B72% with a tw of 11 s (Table 1, Fig. 4b,c). As
mutations to the M1–M2 linker of GlyRa1 have been reported to
strongly affect desensitization17, we focused on the intracellular
end of M3, as we had done with the GABAAR, and exchanged
six consecutive residues with those from r1. This chimera
(GlyRa1r1(D6-postM3)) desensitized byB98% (tw¼ 0.9 s, Fig. 4b),
establishing the intracellular end of M3 in GlyRs as a key
component for desensitization.
We then examined the effect of single mutations towards the
cytoplasmic end of M2 and M3. GlyRa1L298 is the homologous
M3 leucine to GABAAR a1L300. Although the mutant GlyR-
a1L298V did not affect desensitization (Table 1), mutating the
highly conserved M2 glycine in GlyRa1G256V, signiﬁcantly
increased desensitization (% Des¼ 99.4%, tW¼ 0.8 s, Fig. 4c)
while minimally affecting the apparent afﬁnity for glycine
(Supplementary Fig. 2b). Furthermore, mutating the M3 V294
(GlyRa1V294L; homologous to GABAAR a1V296) virtually
abolished desensitization (Fig. 4c). At the intracellular end of
M2 and M3, we then targeted GlyRa1A249 (M2) and GlyRa1N305
(M3), which are homologous to GABAAR a1V251 and a1N307. In
accord with our GABAAR data, the mutant GlyRa1A249F and
GlyRa1N305V displayed near-complete desensitization with rates
13- and 60-fold higher, respectively, than wild-type GlyRa1
(Fig. 4b). This is consistent with our results for a1b2 GABAARs,
and indicates that similar determinants and therefore mechan-
isms of desensitization apply to both GABAARs and GlyRs,
involving structural rearrangements at the cytoplasmic end of the
M2/M3 interface.
Locating the desensitization gate using a channel blocker.
To understand how the identiﬁed residues regulate the desensi-
tization in GABAARs and GlyRs, we compared the crystal
structure of GluCl, with those of ELIC and GLIC, the prokaryotic
homologues of Cys-loop receptors in putative shut and open
conformations, respectively18–20. While receptor activation
involves an increase of the pore diameter between the 90 and
200 positions, there is a corresponding constriction of the pore at
its cytoplasmic end, between  30 and 40 (Fig. 5a)14,18. We
hypothesized that desensitization could be an extension of the
conformational rearrangements that occur during the activation
process, which is consistent with desensitization proceeding
from the open state of the channel21,22. This implies that
desensitization would involve a gate that is located proximal to
the cytoplasmic end of the channel.
To corroborate our desensitization gate model for inhibitory
Cys-loop receptors, we used the pore blocker, picrotoxin (PTX),
since its binding site is generally considered to be located deep in
the pore (between  20 and 20) precisely where the pore constricts
during the activation process (Fig. 5a)14,23. After applying a low
GABA concentration (0.3mM) to a1b2 receptors, enabling the
resting (shut) state(s) of the receptor to remain signiﬁcantly
populated, we co-applied a saturating concentration (50 mM) of
PTX, which blocked the GABA current. Subsequent washout of
PTX while still in GABA revealed an extremely slow dissociation
of the pore blocker (Fig. 5b), consistent with it being trapped in a
resting (shut) state of the channel23. Repeating this protocol now
with a saturating GABA concentration (10mM) to deliberately
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Figure 3 | Effects of mutations a1L300Vb2L296V and a1G258V b2G254V on
GABA sensitivity. GABA concentration–response curves for wild-type (wt)
a1b2 (EC50¼4.1±0.7 mM, nH¼ 1.08±0.07, n¼6), a1L300Vb2L296V
(EC50¼ 7.3±0.9mM, nH¼0.91±0.02, n¼ 5) and a1G258V b2G254V
receptors (EC50¼ 3.0±0.9mM, nH¼0.89±0.19, n¼ 5). Error bars are s.d.
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Figure 4 | Residues affecting desensitization in heteromeric a1b2c2 GABAA receptors and homomeric GlyRa1 glycine receptors. (a) Membrane
currents activated by 10mM GABA showing desensitization of g2 subunit-containing wild-type and mutant GABAA receptors. (b,c) Membrane currents
activated by 10mM glycine, showing desensitization of glycine receptors, both wild type and mutants (see text for details).
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drive receptors into the desensitized state, the apparent
dissociation of PTX was much faster (Fig. 5c). This implies that
PTX is not trapped in a desensitized state and that the
desensitization gate must be distinct from the activation gate
(Model 1, Fig. 6a).
Two simple schemes may explain the fast dissociation of PTX
in the presence of saturating GABA. First, PTX binding/
unbinding could be the same to open and desensitized receptor
states. However, when GABA is saturating, the peak current after
washing out PTX is clearly larger than the steady-state current
before its application, which is not predicted by equal binding/
unbinding to both states (Model 2, Fig. 6b). Second, PTX binding
could be prevented in the desensitized state (Model 3, Fig. 6c).
The recovery of current following PTX removal could then reﬂect
two distinct processes: PTX dissociation from its binding site and
subsequent receptor desensitization. For this scheme, we would
expect the recovery current to exhibit a peak followed by a
plateau. However, such behaviour is not obvious from our
recordings with the GABAAR (Fig. 5c), probably because PTX
dissociation is much slower than the rate of desensitization of
GABAARs (Fig. 6c, Supplementary Table 2).
To gain a clearer view as to where PTX is binding in relation to
our proposed desensitization locus, we examined GlyRs, where
PTX dissociation is notably much faster24,25. During saturating
glycine concentrations, PTX blocked the plateau current (Fig. 7a).
Washing out PTX now revealed a clear peak-plateau current
proﬁle as expected theoretically, indicating that PTX had blocked
the receptor in an open conformation, a proﬁle that is accurately
predicted only by Model 3 (Fig. 7b–d). These observations are
consistent with a mechanism whereby the PTX-binding site
spatially overlaps the desensitization gate. Furthermore, as
desensitization leads to an increase in the agonist occupancy,
such a model could account for the negative allosteric interaction
between the receptor agonist and PTX24,25.
Discussion
The present view of desensitization at Cys-loop receptors is that
the molecular determinants are most likely contained within the
ECD26 or the ECD–TMD coupling interface27,28. Our study
indicates that a different domain is involved whereby the
cytoplasmic end of the ion channel forms a physical
desensitization gate in inhibitory Cys-loop receptors. While this
may initially appear contradictory to earlier studies, a role for
residues in the ECD or the ECD–TMD interface in setting
macroscopic desensitization can be entirely reconciled with our
new view. First, in the event that channel opening precedes
desensitization, a mutation affecting the efﬁcacy of gating could
ultimately affect the macroscopic rate of desensitization without
actually modifying the microscopic rate of desensitization.
Interestingly, the ECD–TMD coupling interface is critical in
setting the efﬁcacy of channel gating. Accordingly, exchanging
residues in this region between nAChRs and 5HT3Rs not only
switches the desensitization properties of the receptors, but also
their single-channel open lifetimes27.
Second, our proposal for a constriction (gate) of the channel
lumen near its intracellular end during desensitization is likely to
be accompanied by conformational rearrangements at the
extracellular end that should be constrained by residues in the
ECD–TMD coupling interface. Considering that M2 helices can
exhibit rigid-body motion during gating12,29, we would predict
that the pore may widen at its extracellular end during
desensitization. This could be consistent with conformational
rearrangements at the ECD–TMD interface of GABAA
receptors during desensitization, as reported by voltage-clamp
ﬂuorometry28. Moreover, such an effect has recently been
proposed for GLIC, using electron paramagnetic resonance
(EPR) spectroscopy to measure the distance between spin-
labelled cysteines introduced along the ion channel pore30.
Interestingly, EPR predicts that desensitization might involve a
mid-membrane gate with the intracellular end of the channel
remaining mostly ﬁxed. However, there are caveats to the
interpretations of EPR data. First, in the narrowest part of the
GLIC channel, spin labels might occlude the pore, thus acting as
pore blockers, and as for PTX-bound GABA receptors,
desensitization could conceivably be prevented by the labelling.
Unfortunately, the irreversible inhibition by pore-blocking spin-
labels would also render these receptors unsuitable for electro-
physiological studies. Second, in the conﬁned space of an ion
channel pore, it is likely that the motion of the spin labels is also
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Figure 5 | Promoting desensitization of GABAARs causes fast dissociation of the pore blocker PTX. (a) Left: side-view cutaway section through the
transmembrane domains showing two (a1—green, b2—red) of the ﬁve M2 helices from our a1b2 GABAAR model overlaid with the M2 helices of the
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dissociation of PTX from a1b2 GABAARs when activated by a low concentration of GABA (0.3 mM, n¼ 6). (c) Membrane currents showing fast dissociation
of PTX from a1b2 GABAARs activated by saturating concentrations of GABA (10mM, n¼ 5). Note the peak currents are truncated for clarity.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7829
6 NATURE COMMUNICATIONS | 6:6829 | DOI: 10.1038/ncomms7829 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
constrained. Thus, conformational changes around the spin labels
could cause dynamic reorientation, making the extraction of
distance information quite challenging31. For these reasons,
EPR spectroscopy could be confounding when studying
conformational rearrangements in the constricted space of an
ion channel.
It is also important to note that a previous study showed that
M1 and M2 were important in setting the desensitization
properties of g2 and d subunit-containing GABAA receptors3.
While the molecular mechanisms were unclear, these results are
interpretable in the light of our present study. The importance of
M2 is clearly demonstrated by our mutagenesis data, and from
our proposal regarding the location of a desensitization gate.
Moreover, as there are extensive interactions between the TMDs,
M1 would be expected to affect the conformation of both M2
and M3, and could also inﬂuence desensitization by affecting the
M1–M2 linker. We should add a cautionary note to emphasize
that perturbations to receptor structure can potentially have far
reaching ramiﬁcations for predicting the consequences of
mutagenesis to a functional outcome. For this reason, it is
hard to predict the effects of residue substitution in the M2–M3
linker when manipulating the side-chain volume, charge and
hydrophobicity. Nevertheless, structure–function studies of
Cys-loop receptor activation, using similar methodologies to
those employed here have proved to be very precise tools in
identifying and attributing key parts of the receptor involved in
function12,29, as evidenced by recent corroborating data between
receptor function and the crystal structure of the apo form of
GluCl32.
The molecular mechanisms underlying the desensitization of
inhibitory Cys-loop receptors, which may conceivably extend to
the entire Cys-loop family, appear strikingly different from the
mechanisms responsible for desensitization of ionotropic GluRs.
This is unsurprising, since from a structural point of view,
Cys-loop receptors are quite distinct from ionotropic GluRs by
forming pentamers with the ECD of each subunit interacting to
form a ring, and the agonist binding sites located at interfaces
between adjacent ECDs7,33. By contrast, ionotropic GluRs
are tetramers harbouring discrete intrasubunit-binding sites7,8.
Moreover, Cys-loop receptor subunits contain four trans-
membrane segments, which differ from the three trans-
membrane segments and one re-entrant P-loop topology of
ionotropic GluR subunits.
The cytoplasmic end of the pore in Cys-loop receptors also
contains the ion selectivity ﬁlter34. The conformational changes
proposed to underlie desensitization here are reminiscent of the
collapse of the selectivity ﬁlter that is considered responsible for
slow inactivation of voltage-gated Kþ and Naþ channels35–37.
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PTX. (a–c) Left: kinetic models 1–3 used to predict the recovery of agonist-
induced currents after wash-out of PTX (or P) in the presence of saturating
concentrations of the agonist ([A]; 10mM GABA). Receptors states are:
R inactive, agonist-unbound receptor; AR inactive, agonist-bound receptor;
AR* agonist-bound activated receptor; AD agonist-bound desensitized
receptor, all with or without bound PTX. Right: predicted membrane
currents, generated from the models, for wild-type a1b2 GABAARs
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See Supplementary Table 2 for the numerical values of the parameters.
(a) Model 1: the PTX-blocked open receptor (AR*P) can desensitize, but
PTX binding and unbinding cannot occur to or from either the resting
(R/RP, AR/ARP) or desensitized (AD/ADP) receptor states. (b) Model 2:
PTX binding and unbinding is permitted to both open (AR*/AR*P) and
desensitized states. (c) Model 3: PTX binding prevents desensitization
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Figure 7 | GlyR current recovery after blockade by PTX under desensitizing conditions. (a) Representative recording of the fast dissociation of PTX from
GlyRa1 activated by high concentrations (10mM) of glycine, accompanied by a clear rebound current (n¼ 5). (b–d) Predicted membrane currents for
activated wild-type GlyRa1 using the kinetic models 1–3, respectively, described in Fig. 6. See Supplementary Table 2 for the numerical values of parameters.
Note, peak currents are truncated for clarity.
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Speciﬁc mutations near the P-loop of these voltage-gated
channels profoundly impact on slow inactivation, in a similar
manner to the effects of the mutations described in this study for
Cys-loop receptor desensitization38,39. Corroboration for the slow
inactivation model of voltage-gated ion channels was obtained
using pore-blockers, such as tetraethylammonium, which reduced
slow inactivation of Shaker Kþ channels by a ‘foot-in-the-door’
mechanism, essentially by binding near the selectivity ﬁlter to
prevent its physical collapse38,40. By analogy, we used the
Cys-loop Cl channel blocker PTX to prevent GABAAR and
GlyR desensitization, which accorded with there being a spatial
overlap between the desensitization gate and the PTX-binding site
in the ion channel. Of note, a recent study showed that, in the
absence of GABA, PTX is trapped in the resting state and not in
the desensitized state23, though prolonged GABA applications
were not investigated, and it therefore remains possible that PTX-
bound receptors might desensitize in the presence of saturating
concentrations of GABA. Indeed, all the models we depict
(Fig. 6a–c) are consistent with the data in ref. 23. To extend this
further, our experimental results show that PTX actually prevents
desensitization even in the presence of saturating concentrations
of GABA. Overall, our study identiﬁes a new potential molecular
mechanism in GABAARs and GlyRs that underpins one of the
most fundamental parameters in pharmacology, that of receptor
desensitization. We also establish a strong parallel between
Cys-loop receptor desensitization and the slow inactivation of
voltage-gated Kþ and Naþ channels, even though the structure
and membrane topology of these tetrameric channels is
completely different from pentameric Cys-loop receptors.
In this context, it is notable that a recent crystal structure for
the GABA receptor b3 homomer has been solved. Although it is
considered not to be a physiological form of the GABAA receptor,
being unable to be activated by GABA41, the crystallographic data
also alludes to a constriction at the intracellular end of the ion
channel pore as being representative of a desensitized state42.
Our model suggests that the desensitization of Cys-loop
receptors involves a rearrangement of the M2/M3 interface. This
concept would accommodate the effects of modulators binding
within the M1/M2/M3 intrasubunit cavity of nAChRs, which
prevent desensitization43–45. Our results therefore provide a
rationale for the mechanism of action of these drugs, and could
help in designing pharmaceutical compounds to modulate
Cys-loop receptor function. This is likely to be beneﬁcial since
Cys-loop receptors are involved in many pathological conditions,
such as addiction, anxiety, depression, neurodegenerative diseases
and seizures46–48.
Methods
Molecular biology. Murine GABAAR a1, b2 and g2 subunits and human r1
subunits were subcloned into pRK5 at the EcoRI site. The human GlyRa1 subunit
was subcloned into pRK5 between the EcoRI and the NotI sites. Most GABAA
chimeric receptors were obtained by ampliﬁcation following a four-step procedure:
ﬁrst, a PCR was performed to build the amino-terminal end of the construct with
the forward primer SP6 (50 to 30 sequence: CACATACGATTTAGGTGACACTA
TAG) and a reverse primer overlapping the junction between the parental DNAs,
followed by DNA puriﬁcation (QIAquick PCR puriﬁcation kit, Qiagen). Second, a
PCR was performed to build the C-terminal end of the construct with the reverse
primer P5 (CAGACATGATAAGATACATTGATGAG) and a forward primer
overlapping the junction between the parental DNAs, followed by DNA puriﬁca-
tion. Third, the PCR products were assembled through a ﬁnal PCR step using SP6
and P5, followed by DNA gel extraction (QIAquick gel extraction kit, Qiagen).
Fourth, the end product was subcloned into pRK5 with the restriction enzymes
ClaI and SalI (NEB), using T4 DNA ligase (Roche). See Supplementary Table 4 for
the primer sequences and the DNA templates used for the chimeras molecular
biology. Single-point mutants and some chimeric receptors with small sequence
exchanges (less than eight residues) were constructed with a single PCR reaction
using Phusion DNA polymerase (Thermoscientiﬁc), followed by DNA gel
extraction, 50 phosphorylation using polynucleotide kinase (NEB) and subsequent
ligation. See Supplementary Table 5 for the primer sequences and the DNA
templates used for these mutant receptors.
Two-electrode voltage clamp and analysis. Xenopus laevis oocytes expressing
recombinant receptors were prepared, injected with complementary DNAs
(cDNAs; at 1–30 ngmL 1), voltage clamped and recorded as described pre-
viously16. All compounds were purchased from Sigma. EDTA (10 mM) was added
to the OR2 solution when recording from oocytes expressing GlyRs to chelate
contaminating Zn2þ , which potentiates GlyR function49. Recordings were
digitized at 500Hz and ﬁltered at 50Hz. Desensitizing currents were induced by
1min agonist applications. The design of our recording chamber and the use of
supersaturating concentrations of agonist enabled us to elicit currents with 20–80%
rise times of 22 and 15ms for wild-type a1b2 GABAARs and GlyRa1, respectively.
The extent of desensitization was determined as
1 IResidual

Ipeak ;
where Ipeak is the agonist-induced peak current and IResidual the residual of this
current remaining at the end of the agonist application. Weighted decay time
constants for desensitization were determined by ﬁtting the desensitizing phase
with two or three exponential components (Clampﬁt ver 8). Experiments that
assessed the time period for recovery of the receptor from desensitization were
performed by ﬁrst driving the receptor into a profound desensitized state (30 s
exposure to millimolar GABA or glycine concentrations), then monitoring the
recovery of peak currents (2 s exposures) repeated at 10, 20, 30, 45, 60, 90, 120,
300 and 600-s intervals after the initial desensitizing exposure to the agonist.
To resolve even faster channel kinetics, we have performed rapid-application
perfusion experiments with outside-out patches pulled from Xenopus laevis oocytes
expressing GABAARs. Using a piezo-driven theta tube, we achieved 20–80%
solution exchange times o100 ms. At wild-type a1b2 GABAARs, a 3-s exposure of
10mM GABA led to a current that desensitized almost completely and is described
by three exponential components of B10, 100 and 500ms, consistent with
published results obtained with recombinant receptors expressed in HEK cells2.
Although the 10-ms component cannot be detected using two-electrode voltage
clamp (TEVC), we should have resolved the 100-ms component using oocytes,
given the 22-ms rise time for GABA-activated currents, and, because exponentials
of this order were detected with some of our mutant receptors. However, we never
resolved such a fast component at wild-type a1b2 GABAARs (fastest component
was B1–2 s). Furthermore, the almost complete extent of fast desensitization in
most outside-out patches did not concur with the large currents obtained with
TEVC after a few seconds of exposure to GABA. Interestingly, recent results
demonstrate that, in whole-cell patch-clamp recordings, GABA- and glycine-
mediated currents decay much faster than their respective membrane conductances
in the continuous presence of the agonist50. Since the decay rates of the currents
were matched by the rates of change of internal Cl concentration, such an
observation led the authors to speculate that the fast decay of currents, initially
thought to reﬂect desensitization, actually reﬂects a decrease in the driving force for
Cl ions. This effect is likely to be present in most patch-clamp experiments
performed on small cells or outside-out patches, especially under high series
resistance conditions. The oocyte is therefore a reliable model system to study the
Cys-loop receptor desensitization. Of note, the slow conductance decay rates
measured in ref. 50 are consistent with the desensitization kinetics we measure in
TEVC at wild-type receptors.
Finally, as mentioned above, we used outside-out patches pulled from oocytes
that expressed mutants showing increased rates of desensitization under TEVC.
Unfortunately, we could not resolve any current from patches containing
a1b2r1(M1M2 link) or a1V251Fb2 receptors, even though the ‘parent’ oocytes
exhibited strong functional expression (45 mA peak GABA current).
Moreover, using outside-out patches from oocytes expressing the mild mutant
a1G258Ab2G254A, we rarely recorded currents, and only then of a few pA decaying
fully within 100ms. For all these reasons, we discarded the fast-perfusion
experiments.
HEK whole-cell patch-clamp recording. HEK cells were transiently transfected
using the calcium phosphate precipitation method with cDNAs pre-mixed in a 1:1
ratio, with 4 mg total cDNA applied to each per 22mm coverslip. HEK cells were
voltage clamped and recorded from as described previously51. Recordings were
digitized and ﬁltered at 6.5 kHz. Desensitizing currents were induced by 8 s
applications of GABA (3mM). The use of a rapid U-tube perfusion system and the
use of supersaturating concentrations of agonist enabled us to elicit currents with
average 20–80% rise times of o8ms for wild-type a1b2 GABAARs. The extent of
desensitization and weighted decay time constants were determined as for TEVC,
up to 6 s after the start of GABA application.
3D molecular modelling and illustration. Modeller (ver 9.7 (ref. 52)) was used to
build 3D homology models of the a1b2 heteromeric GABAAR based on the crystal
structure of GluCl (pdb 3RHW (ref. 14)). Structures were visualized with Pymol53;
pore radii were calculated with MOLE54.
Kinetic modelling. Channelab (ver 2, Synaptosoft, GA) was used to build the
virtual recordings in Figs 6 and 7. The binding and gating rate constants are
broadly consistent with previously published values for GABAARs and GlyRs51,55.
The desensitization rates were chosen to account for the proﬁle of our current
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recordings. We modelled the slow component of receptor desensitization, since this
is the component that is observed in our long duration applications of agonist,
which were used to gather receptors in the desensitized state. The dissociation rate
for PTX used for GABAARs predicted a slow recovery of the current consistent
with our recordings in low concentrations of GABA. The dissociation constant for
PTX (0.4 mM for GABAARs and 10 mM for GlyRs) are consistent with published
IC50 values24,56.
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